Skip to main content
Imaging Biometrics Limited logo

Imaging Biometrics Limited — Investor Relations & Filings

Ticker · IBT ISIN · JE00BD4H0R42 LEI · 213800SPW48XRJS2QH57 IL Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 26 across all filing types
Latest filing 2026-06-05 Regulatory Filings
Country JE Jersey
Listing IL IBT

About Imaging Biometrics Limited

https://www.imagingbiometrics.com/

Imaging Biometrics Limited is a medical technology company specializing in the development of automated software solutions for advanced medical imaging analysis. The company's primary focus is on neuro-oncology, providing clinicians and researchers with tools to more accurately characterize and monitor brain tumors. Its product portfolio features proprietary and quantitative technologies, such as Delta T1 (dT1) and relative Cerebral Blood Volume (rCBV) mapping, which are designed to extract more meaningful information from MRI scans. These intuitive software solutions integrate into existing clinical workflows to assist with diagnosis, surgical planning, and the assessment of treatment response, aiming to enhance decision-making and improve patient care.

Recent filings

Filing Released Lang Actions
Commercialisation, Phase II Results & Revenue Path
Regulatory Filings Classification · 90% confidence The document is an RNS regulatory announcement summarizing clinical trial results (ASCO Phase II) and outlining a commercialisation plan. It does not contain financial statements, capital-raising details, corporate governance changes, or M&A activity. It is a general company news release via the London Stock Exchange’s RNS service, fitting the fallback ‘Regulatory Filings’ category.
2026-06-05 English
Result of AGM
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is an announcement titled “Result of AGM” and provides proxy vote tallies for resolutions passed at the company’s Annual General Meeting. This is exactly a declaration of shareholder voting results at a general meeting, matching the criteria for DVA.
2026-06-03 English
AGM Statement and Business Update
AGM Information Classification · 85% confidence The document is an RNS announcement titled “AGM Statement and Business Update” issued in advance of the company’s Annual General Meeting. It provides business and product updates rather than quarterly results or voting results, and it is intended as informational material for the AGM itself rather than a standalone financial report, executive certification, or dividend notice. This fits the definition of AGM Information (AGM-R).
2026-06-03 English
AMENDEMENT TO NOTICE OF ANNUAL GENERAL MEETING
Report Publication Announcement Classification · 85% confidence The document is a short RNS announcement amending a previously issued Notice of Annual General Meeting (AGM) and stating that the corrected notice will shortly be available on the company website. It does not contain the AGM materials or substantive shareholder voting content itself—rather it announces the publication of a corrected report (the Notice of AGM). Under the “menu vs meal” rule, this is a report publication announcement, not the report itself.
2026-05-13 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 85% confidence The document is a short RNS announcement titled “NOTICE OF ANNUAL GENERAL MEETING,” providing date, location, and summary of resolutions for the AGM. It is not a full annual report, proxy statement, or financial results release, but specifically an announcement concerning the AGM itself. Under our taxonomy, this best matches “AGM Information” (AGM-R).
2026-05-12 English
KIRKSTALL AWARDED BBSRC/NC3Rs GRANT: GLIOBLASTOMA
Regulatory Filings Classification · 95% confidence The document is a regulatory announcement from Imaging Biometrics Limited about a grant awarded to its subsidiary Kirkstall Limited for a research program on glioblastoma 'tumour on a chip' technology. It details the background, research program, funding, strategic significance, and contact information. There are no financial statements, earnings data, or detailed management analysis. The document is an announcement of a research grant and strategic update rather than a financial report or regulatory filing related to financial performance or governance changes. It is not a report publication announcement since it contains substantive information rather than just a notice of report availability. The content fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2026-05-08 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.